<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03544944</url>
  </required_header>
  <id_info>
    <org_study_id>TJP-008-301</org_study_id>
    <nct_id>NCT03544944</nct_id>
  </id_info>
  <brief_title>A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy</brief_title>
  <official_title>A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taejoon Pharmaceutical Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taejoon Pharmaceutical Co., Ltd.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized study compared with active control arm. The investigators
      compare the colon cleansing in patients undergoing colonoscopy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 2, 2018</start_date>
  <completion_date type="Actual">July 30, 2018</completion_date>
  <primary_completion_date type="Actual">May 30, 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ratio of subjects With successful Bowel Cleansing</measure>
    <time_frame>1 day of scheduled colonoscopy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Easch segments ratio of subject with successful Bowel Cleansing</measure>
    <time_frame>1 day of scheduled colonoscopy</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">297</enrollment>
  <condition>Bowel Preparation</condition>
  <arm_group>
    <arm_group_label>TJP-008-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>TJP-008-2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Coolprep powder</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TJP-008-1</intervention_name>
    <description>Subjects who are randomized into group TJP-008-1 will receive bowel preparation on the same-day.</description>
    <arm_group_label>TJP-008-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>TJP-008-2</intervention_name>
    <description>Subjects who are randomized into group TJP-008-2 will receive bowel preparation from evening to next morning.</description>
    <arm_group_label>TJP-008-2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Coolprep powder</intervention_name>
    <description>Subjects who are randomized into group Coolprep will receive bowel preparation from evening to next morning.</description>
    <arm_group_label>Coolprep powder</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients must provide written informed consent.

          -  Male and female outpatients and inpatients aged: ≥19

          -  Patients BMI shoule be ≤ 30

        Exclusion Criteria:

          -  Patients with past history within last 12 months or current episode of severe
             constipation

          -  Known glucose-6-phosphate dehydrogenase (G6PD) deficiency.

          -  Known phenylketonuria.

          -  Clinically relevant findings on physical examination based on the Investigator's
             judgment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Taejoon Pharmaceutical Co., Ltd.</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>May 22, 2018</study_first_submitted>
  <study_first_submitted_qc>June 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2018</study_first_posted>
  <last_update_submitted>September 2, 2019</last_update_submitted>
  <last_update_submitted_qc>September 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bowel preparation</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

